Literature DB >> 28392569

Multichannel polymer scaffold seeded with activated Schwann cells and bone mesenchymal stem cells improves axonal regeneration and functional recovery after rat spinal cord injury.

Er-Zhu Yang1, Guo-Wang Zhang1, Jian-Guang Xu1, Shuai Chen2, Hua Wang3, Liang-Liang Cao1, Bo Liang1, Xiao-Feng Lian1.   

Abstract

The adult mammalian CNS has a limited capacity to regenerate after traumatic injury. In this study, a combinatorial strategy to promote axonal regeneration and functional recovery after spinal cord injury (SCI) was evaluated in adult rats. The rats were subjected to a complete transection in the thoracic spinal cord, and multichannel scaffolds seeded with activated Schwann cells (ASCs) and/or rat bone marrow-derived mesenchymal stem cells (MSCs) were acutely grafted into the 3-mm-wide transection gap. At 4 weeks post-transplantation and thereafter, the rats receiving scaffolds seeded with ASCs and MSCs exhibited significant recovery of nerve function as shown by the Basso, Beattie and Bresnahan (BBB) score and electrophysiological test results. Immunohistochemical analyses at 4 and 8 weeks after transplantation revealed that the implanted MSCs at the lesion/graft site survived and differentiated into neuron-like cells and co-localized with host neurons. Robust bundles of regenerated fibers were identified in the lesion/graft site in the ASC and MSC co-transplantation rats, and neurofilament 200 (NF) staining confirmed that these fibers were axons. Furthermore, myelin basic protein (MBP)-positive myelin sheaths were also identified at the lesion/graft site and confirmed via electron microscopy. In addition to expressing mature neuronal markers, sparse MSC-derived neuron-like cells expressed choline acetyltransferase (ChAT) at the injury site of the ASC and MSC co-transplantation rats. These findings suggest that co-transplantation of ASCs and MSCs in a multichannel polymer scaffold may represent a novel combinatorial strategy for the treatment of spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28392569      PMCID: PMC5457698          DOI: 10.1038/aps.2017.11

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  66 in total

1.  Basic behavior of migratory Schwann cells in peripheral nerve regeneration.

Authors:  K Torigoe; H F Tanaka; A Takahashi; A Awaya; K Hashimoto
Journal:  Exp Neurol       Date:  1996-02       Impact factor: 5.330

2.  Intravenous infusion of mesenchymal stem cells promotes functional recovery in a model of chronic spinal cord injury.

Authors:  Tomonori Morita; Masanori Sasaki; Yuko Kataoka-Sasaki; Masahito Nakazaki; Hiroshi Nagahama; Shinichi Oka; Tsutomu Oshigiri; Tsuneo Takebayashi; Toshihiko Yamashita; Jeffery D Kocsis; Osamu Honmou
Journal:  Neuroscience       Date:  2016-08-30       Impact factor: 3.590

3.  Neurotrophin-3 gene-modified Schwann cells promote TrkC gene-modified mesenchymal stem cells to differentiate into neuron-like cells in poly(lactic-acid-co-glycolic acid) multiple-channel conduit.

Authors:  Yan-qing Zhang; Liu-min He; Bin Xing; Xiang Zeng; Chen-guang Zeng; Wei Zhang; Da-ping Quan; Yuan-shan Zeng
Journal:  Cells Tissues Organs       Date:  2011-08-09       Impact factor: 2.481

4.  Adult bone marrow stromal cells differentiate into neural cells in vitro.

Authors:  J Sanchez-Ramos; S Song; F Cardozo-Pelaez; C Hazzi; T Stedeford; A Willing; T B Freeman; S Saporta; W Janssen; N Patel; D R Cooper; P R Sanberg
Journal:  Exp Neurol       Date:  2000-08       Impact factor: 5.330

5.  In vivo predegeneration of peripheral nerves: an effective technique to obtain activated Schwann cells for nerve conduits.

Authors:  G Keilhoff; H Fansa; W Schneider; G Wolf
Journal:  J Neurosci Methods       Date:  1999-07-01       Impact factor: 2.390

6.  Tissue engineered regeneration of completely transected spinal cord using human mesenchymal stem cells.

Authors:  Kkot Nim Kang; Da Yeon Kim; So Mi Yoon; Ju Young Lee; Bit Na Lee; Jin Seon Kwon; Hyo Won Seo; Il Woo Lee; Ha Cheol Shin; Young Man Kim; Hyun Soo Kim; Jae Ho Kim; Byoung Hyun Min; Hai Bang Lee; Moon Suk Kim
Journal:  Biomaterials       Date:  2012-04-10       Impact factor: 12.479

7.  Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury.

Authors:  Saeed Oraee Yazdani; Maryam Hafizi; Ali-Reza Zali; Amir Atashi; Farzad Ashrafi; Amir-Saeed Seddighi; Masoud Soleimani
Journal:  Cytotherapy       Date:  2013-07       Impact factor: 5.414

8.  Schwann cell but not olfactory ensheathing glia transplants improve hindlimb locomotor performance in the moderately contused adult rat thoracic spinal cord.

Authors:  Toshihiro Takami; Martin Oudega; Margaret L Bates; Patrick M Wood; Naomi Kleitman; Mary Bartlett Bunge
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

Review 9.  Spinal cord repair strategies: why do they work?

Authors:  Elizabeth J Bradbury; Stephen B McMahon
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

10.  Complete rat spinal cord transection as a faithful model of spinal cord injury for translational cell transplantation.

Authors:  Dunja Lukovic; Victoria Moreno-Manzano; Eric Lopez-Mocholi; Francisco Javier Rodriguez-Jiménez; Pavla Jendelova; Eva Sykova; Marc Oria; Miodrag Stojkovic; Slaven Erceg
Journal:  Sci Rep       Date:  2015-04-10       Impact factor: 4.379

View more
  13 in total

1.  Reciprocal nerve staining (RNS) for the concurrent detection of choline acetyltransferase and myelin basic protein on paraffin-embedded sections.

Authors:  Antonio Merolli; Pedro Louro; Joachim Kohn
Journal:  J Neurosci Methods       Date:  2018-11-01       Impact factor: 2.390

2.  Dynamics of tissue ingrowth in SIKVAV-modified highly superporous PHEMA scaffolds with oriented pores after bridging a spinal cord transection.

Authors:  Aleš Hejčl; Jiří Růžička; Vladimír Proks; Hana Macková; Šárka Kubinová; Dmitry Tukmachev; Jiří Cihlář; Daniel Horák; Pavla Jendelová
Journal:  J Mater Sci Mater Med       Date:  2018-06-25       Impact factor: 3.896

3.  Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury.

Authors:  Hui-Quan Duan; Qiu-Li Wu; Xue Yao; Bao-You Fan; Hong-Yu Shi; Chen-Xi Zhao; Yan Zhang; Bo Li; Chao Sun; Xiao-Hong Kong; Xin-Fu Zhou; Shi-Qing Feng
Journal:  CNS Neurosci Ther       Date:  2018-01-19       Impact factor: 5.243

Review 4.  Tissue Engineered Neurovascularization Strategies for Craniofacial Tissue Regeneration.

Authors:  Yiming Li; David Fraser; Jared Mereness; Amy Van Hove; Sayantani Basu; Maureen Newman; Danielle S W Benoit
Journal:  ACS Appl Bio Mater       Date:  2021-11-29

5.  Thermosensitive quaternized chitosan hydrogel scaffolds promote neural differentiation in bone marrow mesenchymal stem cells and functional recovery in a rat spinal cord injury model.

Authors:  Cheng Huang; Yuanbing Liu; Jian Ding; Yongping Dai; Lixiang Le; Liangliang Wang; Erhu Ding; Jiandong Yang
Journal:  Cell Tissue Res       Date:  2021-03-24       Impact factor: 5.249

Review 6.  Mesenchymal Stem/Stromal Cell-Mediated Mitochondrial Transfer and the Therapeutic Potential in Treatment of Neurological Diseases.

Authors:  Deqiang Han; Xin Zheng; Xueyao Wang; Tao Jin; Li Cui; Zhiguo Chen
Journal:  Stem Cells Int       Date:  2020-07-07       Impact factor: 5.443

7.  Experimental Models of Spinal Cord Injury in Laboratory Rats.

Authors:  A N Minakov; A S Chernov; D S Asutin; N A Konovalov; G B Telegin
Journal:  Acta Naturae       Date:  2018 Jul-Sep       Impact factor: 1.845

8.  Precision 3D printed meniscus scaffolds to facilitate hMSCs proliferation and chondrogenic differentiation for tissue regeneration.

Authors:  Xingyu Deng; Xiabin Chen; Fang Geng; Xin Tang; Zhenzhen Li; Jie Zhang; Yikai Wang; Fangqian Wang; Na Zheng; Peng Wang; Xiaohua Yu; Shurong Hou; Wei Zhang
Journal:  J Nanobiotechnology       Date:  2021-12-02       Impact factor: 10.435

Review 9.  Electro-acupuncture and its combination with adult stem cell transplantation for spinal cord injury treatment: A summary of current laboratory findings and a review of literature.

Authors:  Yuan-Shan Zeng; Ying Ding; Hao-Yu Xu; Xiang Zeng; Bi-Qin Lai; Ge Li; Yuan-Huan Ma
Journal:  CNS Neurosci Ther       Date:  2022-02-17       Impact factor: 5.243

Review 10.  Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.

Authors:  Eva Sykova; Dasa Cizkova; Sarka Kubinova
Journal:  Front Cell Dev Biol       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.